mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.2 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.2 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.2 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |